Executive Summary: Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Michael A. Horberg(Kaiser Permanente), Khalil G. Ghanem(Johns Hopkins University), Patricia Emmanuel(University of South Florida), Joel E. Gallant(Gilead Sciences (United States)), Barry S. Zingman(Albert Einstein College of Medicine)
Cited by 266
Related Papers
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2010|725